Index by author

June 01 1999; volume 22 issue 6

A

  1. Ackerson, L M

    1. Excess maternal transmission of type 2 diabetes. The Northern California Kaiser Permanente Diabetes Registry.
      A J Karter, S E Rowell, L M Ackerson, B D Mitchell, A Ferrara, J V Selby and B Newman
      Diabetes Care 1999 Jun; 22 (6): 938-943. https://doi.org/10.2337/diacare.22.6.938

  2. Ahroni, J H

    1. Clinical correlates of plantar pressure among diabetic veterans.
      J H Ahroni, E J Boyko and R C Forsberg
      Diabetes Care 1999 Jun; 22 (6): 965-972. https://doi.org/10.2337/diacare.22.6.965

B

  1. Bantle, J P

    1. Pharmacologic induction of weight loss to treat type 2 diabetes.
      J B Redmon, S K Raatz, C A Kwong, J E Swanson, W Thomas and J P Bantle
      Diabetes Care 1999 Jun; 22 (6): 896-903. https://doi.org/10.2337/diacare.22.6.896

  2. Baron, A D

    1. Impaired glucose tolerance. Why is it not a disease?
      R C Perry and A D Baron
      Diabetes Care 1999 Jun; 22 (6): 883-885. https://doi.org/10.2337/diacare.22.6.883

  3. Belicar, P

    1. Implanted insulin pump may represent a chance for young women with unstable type 1 diabetes to give birth.
      P Belicar, N Jeandidier, E Renard, S Boivin, P Gross, M Pinget and V Lassmann-Vague
      Diabetes Care 1999 Jun; 22 (6): 1001-1002. https://doi.org/10.2337/diacare.22.6.1001

  4. Bell, D S

    1. Gastroparesis cured by gastrectomy.
      D S Bell and F Ovalle
      Diabetes Care 1999 Jun; 22 (6): 1000-1001. https://doi.org/10.2337/diacare.22.6.1000

  5. Benhaddad, A A

    1. Revised concept for the estimation of insulin sensitivity from a single sample.
      E Raynaud, A Perez-Martin, J F Brun, A A Benhaddad and J Mercier
      Diabetes Care 1999 Jun; 22 (6): 1003-1004. https://doi.org/10.2337/diacare.22.6.1003

  6. Bennett, P H

    1. Birth weight, type 2 diabetes, and insulin resistance in Pima Indian children and young adults.
      D Dabelea, D J Pettitt, R L Hanson, G Imperatore, P H Bennett and W C Knowler
      Diabetes Care 1999 Jun; 22 (6): 944-950. https://doi.org/10.2337/diacare.22.6.944

  7. Bergholm, R

    1. Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants.
      S Mäkimattila, M L Liu, J Vakkilainen, A Schlenzka, S Lahdenperä, M Syvänne, M Mäntysaari, P Summanen, R Bergholm, M R Taskinen and H Yki-Järvinen
      Diabetes Care 1999 Jun; 22 (6): 973-981. https://doi.org/10.2337/diacare.22.6.973

  8. Blonde, L

    1. Switching insulin-sensitizing agents in patients with type 2 diabetes who require insulin.
      L Blonde, M I Sandberg and R D Guthrie
      Diabetes Care 1999 Jun; 22 (6): 1004-1006. https://doi.org/10.2337/diacare.22.6.1004a

  9. Bloomgarden, Z T

    1. The European Association for the Study of Diabetes Annual Meeting, 1998. The U.K. Prospective Diabetes Study and other topics in type 2 diabetes.
      Z T Bloomgarden
      Diabetes Care 1999 Jun; 22 (6): 989-995. https://doi.org/10.2337/diacare.22.6.989

  10. Bodansky, H J

    1. Perinatal and neonatal determinants of childhood type 1 diabetes. A case-control study in Yorkshire, U.K.
      P A McKinney, R Parslow, K A Gurney, G R Law, H J Bodansky and R Williams
      Diabetes Care 1999 Jun; 22 (6): 928-932. https://doi.org/10.2337/diacare.22.6.928

  11. Boivin, S

    1. Implanted insulin pump may represent a chance for young women with unstable type 1 diabetes to give birth.
      P Belicar, N Jeandidier, E Renard, S Boivin, P Gross, M Pinget and V Lassmann-Vague
      Diabetes Care 1999 Jun; 22 (6): 1001-1002. https://doi.org/10.2337/diacare.22.6.1001

  12. Bouma, M

    1. How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes?
      M Bouma, J H Dekker, J J de Sonnaville, F E van der Does, H de Vries, D M Kriegsman, P J Kostense, R J Heine and J T van Eijk
      Diabetes Care 1999 Jun; 22 (6): 904-907. https://doi.org/10.2337/diacare.22.6.904

  13. Boyko, E J

    1. Clinical correlates of plantar pressure among diabetic veterans.
      J H Ahroni, E J Boyko and R C Forsberg
      Diabetes Care 1999 Jun; 22 (6): 965-972. https://doi.org/10.2337/diacare.22.6.965

  14. Brighenti, F

    1. Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial.
      V Vuksan, D J Jenkins, P Spadafora, J L Sievenpiper, R Owen, E Vidgen, F Brighenti, R Josse, L A Leiter and C Bruce-Thompson
      Diabetes Care 1999 Jun; 22 (6): 913-919. https://doi.org/10.2337/diacare.22.6.913

  15. Bruce-Thompson, C

    1. Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial.
      V Vuksan, D J Jenkins, P Spadafora, J L Sievenpiper, R Owen, E Vidgen, F Brighenti, R Josse, L A Leiter and C Bruce-Thompson
      Diabetes Care 1999 Jun; 22 (6): 913-919. https://doi.org/10.2337/diacare.22.6.913

  16. Brun, J F

    1. Revised concept for the estimation of insulin sensitivity from a single sample.
      E Raynaud, A Perez-Martin, J F Brun, A A Benhaddad and J Mercier
      Diabetes Care 1999 Jun; 22 (6): 1003-1004. https://doi.org/10.2337/diacare.22.6.1003

  17. Butler-Jones, D

    1. Incidence of lactic acidosis in metformin users.
      M Stang, D K Wysowski and D Butler-Jones
      Diabetes Care 1999 Jun; 22 (6): 925-927. https://doi.org/10.2337/diacare.22.6.925

C

  1. Casey, E

    1. Central pontine myelinolysis. An unusual complication of diabetes.
      E Casey, A Evans, A Krentz, P Watkins and D Hopkins
      Diabetes Care 1999 Jun; 22 (6): 998-1000. https://doi.org/10.2337/diacare.22.6.998

  2. Clifton, P M

    1. Effect of energy restriction, weight loss, and diet composition on plasma lipids and glucose in patients with type 2 diabetes.
      L K Heilbronn, M Noakes and P M Clifton
      Diabetes Care 1999 Jun; 22 (6): 889-895. https://doi.org/10.2337/diacare.22.6.889

  3. Cohen, R D

    1. Metformin and lactic acidosis.
      R D Cohen and H F Woods
      Diabetes Care 1999 Jun; 22 (6): 1010-1011. https://doi.org/10.2337/diacare.22.6.1010

  4. Cull, C A

    1. A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)
      R R Holman, C A Cull and R C Turner
      Diabetes Care 1999 Jun; 22 (6): 960-964. https://doi.org/10.2337/diacare.22.6.960

D

  1. Dabelea, D

    1. Birth weight, type 2 diabetes, and insulin resistance in Pima Indian children and young adults.
      D Dabelea, D J Pettitt, R L Hanson, G Imperatore, P H Bennett and W C Knowler
      Diabetes Care 1999 Jun; 22 (6): 944-950. https://doi.org/10.2337/diacare.22.6.944

  2. Dekker, J H

    1. How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes?
      M Bouma, J H Dekker, J J de Sonnaville, F E van der Does, H de Vries, D M Kriegsman, P J Kostense, R J Heine and J T van Eijk
      Diabetes Care 1999 Jun; 22 (6): 904-907. https://doi.org/10.2337/diacare.22.6.904

  3. de Sonnaville, J J

    1. How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes?
      M Bouma, J H Dekker, J J de Sonnaville, F E van der Does, H de Vries, D M Kriegsman, P J Kostense, R J Heine and J T van Eijk
      Diabetes Care 1999 Jun; 22 (6): 904-907. https://doi.org/10.2337/diacare.22.6.904

  4. de Swiet, M

    1. Implications of new diagnostic criteria for abnormal glucose homeostasis in women with previous gestational diabetes.
      E Kousta, N J Lawrence, A Penny, B A Millauer, S Robinson, A Dornhorst, M de Swiet, P J Steer, A Grenfell, H M Mather, D G Johnston and M I McCarthy
      Diabetes Care 1999 Jun; 22 (6): 933-937. https://doi.org/10.2337/diacare.22.6.933

  5. de Vries, H

    1. How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes?
      M Bouma, J H Dekker, J J de Sonnaville, F E van der Does, H de Vries, D M Kriegsman, P J Kostense, R J Heine and J T van Eijk
      Diabetes Care 1999 Jun; 22 (6): 904-907. https://doi.org/10.2337/diacare.22.6.904

  6. Dornhorst, A

    1. Implications of new diagnostic criteria for abnormal glucose homeostasis in women with previous gestational diabetes.
      E Kousta, N J Lawrence, A Penny, B A Millauer, S Robinson, A Dornhorst, M de Swiet, P J Steer, A Grenfell, H M Mather, D G Johnston and M I McCarthy
      Diabetes Care 1999 Jun; 22 (6): 933-937. https://doi.org/10.2337/diacare.22.6.933

E

  1. Eguchi, H

    1. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.
      M Tominaga, H Eguchi, H Manaka, K Igarashi, T Kato and A Sekikawa
      Diabetes Care 1999 Jun; 22 (6): 920-924. https://doi.org/10.2337/diacare.22.6.920

  2. Epstein, M

    1. Effects of diabetes on cardiovascular drug metabolism. Emerging clinical implications.
      R A Preston and M Epstein
      Diabetes Care 1999 Jun; 22 (6): 982-988. https://doi.org/10.2337/diacare.22.6.982

  3. Evans, A

    1. Central pontine myelinolysis. An unusual complication of diabetes.
      E Casey, A Evans, A Krentz, P Watkins and D Hopkins
      Diabetes Care 1999 Jun; 22 (6): 998-1000. https://doi.org/10.2337/diacare.22.6.998

F

  1. Ferrara, A

    1. Excess maternal transmission of type 2 diabetes. The Northern California Kaiser Permanente Diabetes Registry.
      A J Karter, S E Rowell, L M Ackerson, B D Mitchell, A Ferrara, J V Selby and B Newman
      Diabetes Care 1999 Jun; 22 (6): 938-943. https://doi.org/10.2337/diacare.22.6.938

  2. Forsberg, R C

    1. Clinical correlates of plantar pressure among diabetic veterans.
      J H Ahroni, E J Boyko and R C Forsberg
      Diabetes Care 1999 Jun; 22 (6): 965-972. https://doi.org/10.2337/diacare.22.6.965

  3. Fukui, M

    1. GAD antibodies in classification of Asian type 2 diabetes.
      M Fukui, N Nakamura and M Kondo
      Diabetes Care 1999 Jun; 22 (6): 1011-1012. https://doi.org/10.2337/diacare.22.6.1011

G

  1. Gatta, B

    1. Diabetic ketoacidosis with olanzapine treatment.
      B Gatta, V Rigalleau and H Gin
      Diabetes Care 1999 Jun; 22 (6): 1002-1003. https://doi.org/10.2337/diacare.22.6.1002

  2. Gin, H

    1. Diabetic ketoacidosis with olanzapine treatment.
      B Gatta, V Rigalleau and H Gin
      Diabetes Care 1999 Jun; 22 (6): 1002-1003. https://doi.org/10.2337/diacare.22.6.1002

  3. Grenfell, A

    1. Implications of new diagnostic criteria for abnormal glucose homeostasis in women with previous gestational diabetes.
      E Kousta, N J Lawrence, A Penny, B A Millauer, S Robinson, A Dornhorst, M de Swiet, P J Steer, A Grenfell, H M Mather, D G Johnston and M I McCarthy
      Diabetes Care 1999 Jun; 22 (6): 933-937. https://doi.org/10.2337/diacare.22.6.933

  4. Gross, P

    1. Implanted insulin pump may represent a chance for young women with unstable type 1 diabetes to give birth.
      P Belicar, N Jeandidier, E Renard, S Boivin, P Gross, M Pinget and V Lassmann-Vague
      Diabetes Care 1999 Jun; 22 (6): 1001-1002. https://doi.org/10.2337/diacare.22.6.1001

  5. Gumbiner, B

    1. Treating obesity in type 2 diabetes. Calories, composition, and control.
      B Gumbiner
      Diabetes Care 1999 Jun; 22 (6): 886-888. https://doi.org/10.2337/diacare.22.6.886

  6. Gunczler, P

    1. Poor metabolic control decreases the growth velocity of diabetic children.
      P Gunczler and R Lanes
      Diabetes Care 1999 Jun; 22 (6): 1012. https://doi.org/10.2337/diacare.22.6.1012

  7. Gurney, K A

    1. Perinatal and neonatal determinants of childhood type 1 diabetes. A case-control study in Yorkshire, U.K.
      P A McKinney, R Parslow, K A Gurney, G R Law, H J Bodansky and R Williams
      Diabetes Care 1999 Jun; 22 (6): 928-932. https://doi.org/10.2337/diacare.22.6.928

  8. Guthrie, R D

    1. Switching insulin-sensitizing agents in patients with type 2 diabetes who require insulin.
      L Blonde, M I Sandberg and R D Guthrie
      Diabetes Care 1999 Jun; 22 (6): 1004-1006. https://doi.org/10.2337/diacare.22.6.1004a

H

  1. Hänninen, J A

    1. Depression in subjects with type 2 diabetes. Predictive factors and relation to quality of life.
      J A Hänninen, J K Takala and S M Keinänen-Kiukaanniemi
      Diabetes Care 1999 Jun; 22 (6): 997-998. https://doi.org/10.2337/diacare.22.6.997

  2. Hanson, R L

    1. Birth weight, type 2 diabetes, and insulin resistance in Pima Indian children and young adults.
      D Dabelea, D J Pettitt, R L Hanson, G Imperatore, P H Bennett and W C Knowler
      Diabetes Care 1999 Jun; 22 (6): 944-950. https://doi.org/10.2337/diacare.22.6.944

  3. Heilbronn, L K

    1. Effect of energy restriction, weight loss, and diet composition on plasma lipids and glucose in patients with type 2 diabetes.
      L K Heilbronn, M Noakes and P M Clifton
      Diabetes Care 1999 Jun; 22 (6): 889-895. https://doi.org/10.2337/diacare.22.6.889

  4. Heine, R J

    1. How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes?
      M Bouma, J H Dekker, J J de Sonnaville, F E van der Does, H de Vries, D M Kriegsman, P J Kostense, R J Heine and J T van Eijk
      Diabetes Care 1999 Jun; 22 (6): 904-907. https://doi.org/10.2337/diacare.22.6.904

  5. Holman, R R

    1. A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)
      R R Holman, C A Cull and R C Turner
      Diabetes Care 1999 Jun; 22 (6): 960-964. https://doi.org/10.2337/diacare.22.6.960

  6. Hopkins, D

    1. Central pontine myelinolysis. An unusual complication of diabetes.
      E Casey, A Evans, A Krentz, P Watkins and D Hopkins
      Diabetes Care 1999 Jun; 22 (6): 998-1000. https://doi.org/10.2337/diacare.22.6.998

  7. Horikoshi, H

    1. Effect of troglitazone on body fat distribution in type 2 diabetic patients.
      Y Mori, Y Murakawa, K Okada, H Horikoshi, J Yokoyama, N Tajima and Y Ikeda
      Diabetes Care 1999 Jun; 22 (6): 908-912. https://doi.org/10.2337/diacare.22.6.908

  8. Hunkert, F

    1. Potential impact of HbA1c determination on clinical decision making in patients with cystic fibrosis-related diabetes.
      F Hunkert, T Lietz, B Stach and W Kiess
      Diabetes Care 1999 Jun; 22 (6): 1008-1010. https://doi.org/10.2337/diacare.22.6.1008

I

  1. Igarashi, K

    1. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.
      M Tominaga, H Eguchi, H Manaka, K Igarashi, T Kato and A Sekikawa
      Diabetes Care 1999 Jun; 22 (6): 920-924. https://doi.org/10.2337/diacare.22.6.920

  2. Ikeda, Y

    1. Effect of troglitazone on body fat distribution in type 2 diabetic patients.
      Y Mori, Y Murakawa, K Okada, H Horikoshi, J Yokoyama, N Tajima and Y Ikeda
      Diabetes Care 1999 Jun; 22 (6): 908-912. https://doi.org/10.2337/diacare.22.6.908

  3. Imperatore, G

    1. Birth weight, type 2 diabetes, and insulin resistance in Pima Indian children and young adults.
      D Dabelea, D J Pettitt, R L Hanson, G Imperatore, P H Bennett and W C Knowler
      Diabetes Care 1999 Jun; 22 (6): 944-950. https://doi.org/10.2337/diacare.22.6.944

J

  1. Jeandidier, N

    1. Implanted insulin pump may represent a chance for young women with unstable type 1 diabetes to give birth.
      P Belicar, N Jeandidier, E Renard, S Boivin, P Gross, M Pinget and V Lassmann-Vague
      Diabetes Care 1999 Jun; 22 (6): 1001-1002. https://doi.org/10.2337/diacare.22.6.1001

  2. Jenkins, D J

    1. Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial.
      V Vuksan, D J Jenkins, P Spadafora, J L Sievenpiper, R Owen, E Vidgen, F Brighenti, R Josse, L A Leiter and C Bruce-Thompson
      Diabetes Care 1999 Jun; 22 (6): 913-919. https://doi.org/10.2337/diacare.22.6.913

  3. Johnston, D G

    1. Implications of new diagnostic criteria for abnormal glucose homeostasis in women with previous gestational diabetes.
      E Kousta, N J Lawrence, A Penny, B A Millauer, S Robinson, A Dornhorst, M de Swiet, P J Steer, A Grenfell, H M Mather, D G Johnston and M I McCarthy
      Diabetes Care 1999 Jun; 22 (6): 933-937. https://doi.org/10.2337/diacare.22.6.933

  4. Josse, R

    1. Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial.
      V Vuksan, D J Jenkins, P Spadafora, J L Sievenpiper, R Owen, E Vidgen, F Brighenti, R Josse, L A Leiter and C Bruce-Thompson
      Diabetes Care 1999 Jun; 22 (6): 913-919. https://doi.org/10.2337/diacare.22.6.913

K

  1. Karter, A J

    1. Excess maternal transmission of type 2 diabetes. The Northern California Kaiser Permanente Diabetes Registry.
      A J Karter, S E Rowell, L M Ackerson, B D Mitchell, A Ferrara, J V Selby and B Newman
      Diabetes Care 1999 Jun; 22 (6): 938-943. https://doi.org/10.2337/diacare.22.6.938

  2. Kato, T

    1. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.
      M Tominaga, H Eguchi, H Manaka, K Igarashi, T Kato and A Sekikawa
      Diabetes Care 1999 Jun; 22 (6): 920-924. https://doi.org/10.2337/diacare.22.6.920

  3. Keinänen-Kiukaanniemi, S M

    1. Depression in subjects with type 2 diabetes. Predictive factors and relation to quality of life.
      J A Hänninen, J K Takala and S M Keinänen-Kiukaanniemi
      Diabetes Care 1999 Jun; 22 (6): 997-998. https://doi.org/10.2337/diacare.22.6.997

  4. Kiess, W

    1. Potential impact of HbA1c determination on clinical decision making in patients with cystic fibrosis-related diabetes.
      F Hunkert, T Lietz, B Stach and W Kiess
      Diabetes Care 1999 Jun; 22 (6): 1008-1010. https://doi.org/10.2337/diacare.22.6.1008

  5. Klein, B E

    1. The 14-year incidence of lower-extremity amputations in a diabetic population. The Wisconsin Epidemiologic Study of Diabetic Retinopathy.
      S E Moss, R Klein and B E Klein
      Diabetes Care 1999 Jun; 22 (6): 951-959. https://doi.org/10.2337/diacare.22.6.951

  6. Klein, R

    1. The 14-year incidence of lower-extremity amputations in a diabetic population. The Wisconsin Epidemiologic Study of Diabetic Retinopathy.
      S E Moss, R Klein and B E Klein
      Diabetes Care 1999 Jun; 22 (6): 951-959. https://doi.org/10.2337/diacare.22.6.951

  7. Knowler, W C

    1. Birth weight, type 2 diabetes, and insulin resistance in Pima Indian children and young adults.
      D Dabelea, D J Pettitt, R L Hanson, G Imperatore, P H Bennett and W C Knowler
      Diabetes Care 1999 Jun; 22 (6): 944-950. https://doi.org/10.2337/diacare.22.6.944

  8. Kobayashi, K

    1. Acute hyperinsulinemia reduces plasma concentrations of homocysteine in healthy men.
      Y Nagai, T Takamura, E Nohara, H Yamashita and K Kobayashi
      Diabetes Care 1999 Jun; 22 (6): 1004. https://doi.org/10.2337/diacare.22.6.1004b

  9. Kondo, M

    1. GAD antibodies in classification of Asian type 2 diabetes.
      M Fukui, N Nakamura and M Kondo
      Diabetes Care 1999 Jun; 22 (6): 1011-1012. https://doi.org/10.2337/diacare.22.6.1011

  10. Kostense, P J

    1. How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes?
      M Bouma, J H Dekker, J J de Sonnaville, F E van der Does, H de Vries, D M Kriegsman, P J Kostense, R J Heine and J T van Eijk
      Diabetes Care 1999 Jun; 22 (6): 904-907. https://doi.org/10.2337/diacare.22.6.904

  11. Kousta, E

    1. Implications of new diagnostic criteria for abnormal glucose homeostasis in women with previous gestational diabetes.
      E Kousta, N J Lawrence, A Penny, B A Millauer, S Robinson, A Dornhorst, M de Swiet, P J Steer, A Grenfell, H M Mather, D G Johnston and M I McCarthy
      Diabetes Care 1999 Jun; 22 (6): 933-937. https://doi.org/10.2337/diacare.22.6.933

  12. Krentz, A

    1. Central pontine myelinolysis. An unusual complication of diabetes.
      E Casey, A Evans, A Krentz, P Watkins and D Hopkins
      Diabetes Care 1999 Jun; 22 (6): 998-1000. https://doi.org/10.2337/diacare.22.6.998

  13. Kriegsman, D M

    1. How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes?
      M Bouma, J H Dekker, J J de Sonnaville, F E van der Does, H de Vries, D M Kriegsman, P J Kostense, R J Heine and J T van Eijk
      Diabetes Care 1999 Jun; 22 (6): 904-907. https://doi.org/10.2337/diacare.22.6.904

  14. Kwong, C A

    1. Pharmacologic induction of weight loss to treat type 2 diabetes.
      J B Redmon, S K Raatz, C A Kwong, J E Swanson, W Thomas and J P Bantle
      Diabetes Care 1999 Jun; 22 (6): 896-903. https://doi.org/10.2337/diacare.22.6.896

L

  1. Lahdenperä, S

    1. Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants.
      S Mäkimattila, M L Liu, J Vakkilainen, A Schlenzka, S Lahdenperä, M Syvänne, M Mäntysaari, P Summanen, R Bergholm, M R Taskinen and H Yki-Järvinen
      Diabetes Care 1999 Jun; 22 (6): 973-981. https://doi.org/10.2337/diacare.22.6.973

  2. Lanes, R

    1. Poor metabolic control decreases the growth velocity of diabetic children.
      P Gunczler and R Lanes
      Diabetes Care 1999 Jun; 22 (6): 1012. https://doi.org/10.2337/diacare.22.6.1012

  3. Lassmann-Vague, V

    1. Implanted insulin pump may represent a chance for young women with unstable type 1 diabetes to give birth.
      P Belicar, N Jeandidier, E Renard, S Boivin, P Gross, M Pinget and V Lassmann-Vague
      Diabetes Care 1999 Jun; 22 (6): 1001-1002. https://doi.org/10.2337/diacare.22.6.1001

  4. Law, G R

    1. Perinatal and neonatal determinants of childhood type 1 diabetes. A case-control study in Yorkshire, U.K.
      P A McKinney, R Parslow, K A Gurney, G R Law, H J Bodansky and R Williams
      Diabetes Care 1999 Jun; 22 (6): 928-932. https://doi.org/10.2337/diacare.22.6.928

  5. Lawrence, N J

    1. Implications of new diagnostic criteria for abnormal glucose homeostasis in women with previous gestational diabetes.
      E Kousta, N J Lawrence, A Penny, B A Millauer, S Robinson, A Dornhorst, M de Swiet, P J Steer, A Grenfell, H M Mather, D G Johnston and M I McCarthy
      Diabetes Care 1999 Jun; 22 (6): 933-937. https://doi.org/10.2337/diacare.22.6.933

  6. Leiter, L A

    1. Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial.
      V Vuksan, D J Jenkins, P Spadafora, J L Sievenpiper, R Owen, E Vidgen, F Brighenti, R Josse, L A Leiter and C Bruce-Thompson
      Diabetes Care 1999 Jun; 22 (6): 913-919. https://doi.org/10.2337/diacare.22.6.913

  7. Lietz, T

    1. Potential impact of HbA1c determination on clinical decision making in patients with cystic fibrosis-related diabetes.
      F Hunkert, T Lietz, B Stach and W Kiess
      Diabetes Care 1999 Jun; 22 (6): 1008-1010. https://doi.org/10.2337/diacare.22.6.1008

  8. Liu, M L

    1. Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants.
      S Mäkimattila, M L Liu, J Vakkilainen, A Schlenzka, S Lahdenperä, M Syvänne, M Mäntysaari, P Summanen, R Bergholm, M R Taskinen and H Yki-Järvinen
      Diabetes Care 1999 Jun; 22 (6): 973-981. https://doi.org/10.2337/diacare.22.6.973

M

  1. Mackay, I R

    1. GAD antibodies in elderly men in different categories of glucose tolerance.
      H Ylihärsilä, J Tuomilehto, I R Mackay, P Zimmet, E Tuomilehto-Wolf, M J Rowley and A Nissinen
      Diabetes Care 1999 Jun; 22 (6): 996-997. https://doi.org/10.2337/diacare.22.6.996

  2. Mäkimattila, S

    1. Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants.
      S Mäkimattila, M L Liu, J Vakkilainen, A Schlenzka, S Lahdenperä, M Syvänne, M Mäntysaari, P Summanen, R Bergholm, M R Taskinen and H Yki-Järvinen
      Diabetes Care 1999 Jun; 22 (6): 973-981. https://doi.org/10.2337/diacare.22.6.973

  3. Manaka, H

    1. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.
      M Tominaga, H Eguchi, H Manaka, K Igarashi, T Kato and A Sekikawa
      Diabetes Care 1999 Jun; 22 (6): 920-924. https://doi.org/10.2337/diacare.22.6.920

  4. Mäntysaari, M

    1. Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants.
      S Mäkimattila, M L Liu, J Vakkilainen, A Schlenzka, S Lahdenperä, M Syvänne, M Mäntysaari, P Summanen, R Bergholm, M R Taskinen and H Yki-Järvinen
      Diabetes Care 1999 Jun; 22 (6): 973-981. https://doi.org/10.2337/diacare.22.6.973

  5. Mather, H M

    1. Implications of new diagnostic criteria for abnormal glucose homeostasis in women with previous gestational diabetes.
      E Kousta, N J Lawrence, A Penny, B A Millauer, S Robinson, A Dornhorst, M de Swiet, P J Steer, A Grenfell, H M Mather, D G Johnston and M I McCarthy
      Diabetes Care 1999 Jun; 22 (6): 933-937. https://doi.org/10.2337/diacare.22.6.933

  6. McCarthy, M I

    1. Implications of new diagnostic criteria for abnormal glucose homeostasis in women with previous gestational diabetes.
      E Kousta, N J Lawrence, A Penny, B A Millauer, S Robinson, A Dornhorst, M de Swiet, P J Steer, A Grenfell, H M Mather, D G Johnston and M I McCarthy
      Diabetes Care 1999 Jun; 22 (6): 933-937. https://doi.org/10.2337/diacare.22.6.933

  7. McKinney, P A

    1. Perinatal and neonatal determinants of childhood type 1 diabetes. A case-control study in Yorkshire, U.K.
      P A McKinney, R Parslow, K A Gurney, G R Law, H J Bodansky and R Williams
      Diabetes Care 1999 Jun; 22 (6): 928-932. https://doi.org/10.2337/diacare.22.6.928

  8. Mercier, J

    1. Revised concept for the estimation of insulin sensitivity from a single sample.
      E Raynaud, A Perez-Martin, J F Brun, A A Benhaddad and J Mercier
      Diabetes Care 1999 Jun; 22 (6): 1003-1004. https://doi.org/10.2337/diacare.22.6.1003

  9. Millauer, B A

    1. Implications of new diagnostic criteria for abnormal glucose homeostasis in women with previous gestational diabetes.
      E Kousta, N J Lawrence, A Penny, B A Millauer, S Robinson, A Dornhorst, M de Swiet, P J Steer, A Grenfell, H M Mather, D G Johnston and M I McCarthy
      Diabetes Care 1999 Jun; 22 (6): 933-937. https://doi.org/10.2337/diacare.22.6.933

  10. Mitchell, B D

    1. Excess maternal transmission of type 2 diabetes. The Northern California Kaiser Permanente Diabetes Registry.
      A J Karter, S E Rowell, L M Ackerson, B D Mitchell, A Ferrara, J V Selby and B Newman
      Diabetes Care 1999 Jun; 22 (6): 938-943. https://doi.org/10.2337/diacare.22.6.938

  11. Mora, C

    1. Antiproteinuric effect of pentoxifylline in patients with diabetic nephropathy.
      J F Navarro and C Mora
      Diabetes Care 1999 Jun; 22 (6): 1006-1008. https://doi.org/10.2337/diacare.22.6.1006

  12. Mori, Y

    1. Effect of troglitazone on body fat distribution in type 2 diabetic patients.
      Y Mori, Y Murakawa, K Okada, H Horikoshi, J Yokoyama, N Tajima and Y Ikeda
      Diabetes Care 1999 Jun; 22 (6): 908-912. https://doi.org/10.2337/diacare.22.6.908

  13. Moss, S E

    1. The 14-year incidence of lower-extremity amputations in a diabetic population. The Wisconsin Epidemiologic Study of Diabetic Retinopathy.
      S E Moss, R Klein and B E Klein
      Diabetes Care 1999 Jun; 22 (6): 951-959. https://doi.org/10.2337/diacare.22.6.951

  14. Murakawa, Y

    1. Effect of troglitazone on body fat distribution in type 2 diabetic patients.
      Y Mori, Y Murakawa, K Okada, H Horikoshi, J Yokoyama, N Tajima and Y Ikeda
      Diabetes Care 1999 Jun; 22 (6): 908-912. https://doi.org/10.2337/diacare.22.6.908

N

  1. Nagai, Y

    1. Acute hyperinsulinemia reduces plasma concentrations of homocysteine in healthy men.
      Y Nagai, T Takamura, E Nohara, H Yamashita and K Kobayashi
      Diabetes Care 1999 Jun; 22 (6): 1004. https://doi.org/10.2337/diacare.22.6.1004b

  2. Nakamura, N

    1. GAD antibodies in classification of Asian type 2 diabetes.
      M Fukui, N Nakamura and M Kondo
      Diabetes Care 1999 Jun; 22 (6): 1011-1012. https://doi.org/10.2337/diacare.22.6.1011

  3. Navarro, J F

    1. Antiproteinuric effect of pentoxifylline in patients with diabetic nephropathy.
      J F Navarro and C Mora
      Diabetes Care 1999 Jun; 22 (6): 1006-1008. https://doi.org/10.2337/diacare.22.6.1006

  4. Newman, B

    1. Excess maternal transmission of type 2 diabetes. The Northern California Kaiser Permanente Diabetes Registry.
      A J Karter, S E Rowell, L M Ackerson, B D Mitchell, A Ferrara, J V Selby and B Newman
      Diabetes Care 1999 Jun; 22 (6): 938-943. https://doi.org/10.2337/diacare.22.6.938

  5. Nissinen, A

    1. GAD antibodies in elderly men in different categories of glucose tolerance.
      H Ylihärsilä, J Tuomilehto, I R Mackay, P Zimmet, E Tuomilehto-Wolf, M J Rowley and A Nissinen
      Diabetes Care 1999 Jun; 22 (6): 996-997. https://doi.org/10.2337/diacare.22.6.996

  6. Noakes, M

    1. Effect of energy restriction, weight loss, and diet composition on plasma lipids and glucose in patients with type 2 diabetes.
      L K Heilbronn, M Noakes and P M Clifton
      Diabetes Care 1999 Jun; 22 (6): 889-895. https://doi.org/10.2337/diacare.22.6.889

  7. Nohara, E

    1. Acute hyperinsulinemia reduces plasma concentrations of homocysteine in healthy men.
      Y Nagai, T Takamura, E Nohara, H Yamashita and K Kobayashi
      Diabetes Care 1999 Jun; 22 (6): 1004. https://doi.org/10.2337/diacare.22.6.1004b

O

  1. Okada, K

    1. Effect of troglitazone on body fat distribution in type 2 diabetic patients.
      Y Mori, Y Murakawa, K Okada, H Horikoshi, J Yokoyama, N Tajima and Y Ikeda
      Diabetes Care 1999 Jun; 22 (6): 908-912. https://doi.org/10.2337/diacare.22.6.908

  2. Ovalle, F

    1. Gastroparesis cured by gastrectomy.
      D S Bell and F Ovalle
      Diabetes Care 1999 Jun; 22 (6): 1000-1001. https://doi.org/10.2337/diacare.22.6.1000

  3. Owen, R

    1. Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial.
      V Vuksan, D J Jenkins, P Spadafora, J L Sievenpiper, R Owen, E Vidgen, F Brighenti, R Josse, L A Leiter and C Bruce-Thompson
      Diabetes Care 1999 Jun; 22 (6): 913-919. https://doi.org/10.2337/diacare.22.6.913

P

  1. Parslow, R

    1. Perinatal and neonatal determinants of childhood type 1 diabetes. A case-control study in Yorkshire, U.K.
      P A McKinney, R Parslow, K A Gurney, G R Law, H J Bodansky and R Williams
      Diabetes Care 1999 Jun; 22 (6): 928-932. https://doi.org/10.2337/diacare.22.6.928

  2. Penny, A

    1. Implications of new diagnostic criteria for abnormal glucose homeostasis in women with previous gestational diabetes.
      E Kousta, N J Lawrence, A Penny, B A Millauer, S Robinson, A Dornhorst, M de Swiet, P J Steer, A Grenfell, H M Mather, D G Johnston and M I McCarthy
      Diabetes Care 1999 Jun; 22 (6): 933-937. https://doi.org/10.2337/diacare.22.6.933

  3. Perez-Martin, A

    1. Revised concept for the estimation of insulin sensitivity from a single sample.
      E Raynaud, A Perez-Martin, J F Brun, A A Benhaddad and J Mercier
      Diabetes Care 1999 Jun; 22 (6): 1003-1004. https://doi.org/10.2337/diacare.22.6.1003

  4. Perry, R C

    1. Impaired glucose tolerance. Why is it not a disease?
      R C Perry and A D Baron
      Diabetes Care 1999 Jun; 22 (6): 883-885. https://doi.org/10.2337/diacare.22.6.883

  5. Pettitt, D J

    1. Birth weight, type 2 diabetes, and insulin resistance in Pima Indian children and young adults.
      D Dabelea, D J Pettitt, R L Hanson, G Imperatore, P H Bennett and W C Knowler
      Diabetes Care 1999 Jun; 22 (6): 944-950. https://doi.org/10.2337/diacare.22.6.944

  6. Pinget, M

    1. Implanted insulin pump may represent a chance for young women with unstable type 1 diabetes to give birth.
      P Belicar, N Jeandidier, E Renard, S Boivin, P Gross, M Pinget and V Lassmann-Vague
      Diabetes Care 1999 Jun; 22 (6): 1001-1002. https://doi.org/10.2337/diacare.22.6.1001

  7. Preston, R A

    1. Effects of diabetes on cardiovascular drug metabolism. Emerging clinical implications.
      R A Preston and M Epstein
      Diabetes Care 1999 Jun; 22 (6): 982-988. https://doi.org/10.2337/diacare.22.6.982

R

  1. Raatz, S K

    1. Pharmacologic induction of weight loss to treat type 2 diabetes.
      J B Redmon, S K Raatz, C A Kwong, J E Swanson, W Thomas and J P Bantle
      Diabetes Care 1999 Jun; 22 (6): 896-903. https://doi.org/10.2337/diacare.22.6.896

  2. Raynaud, E

    1. Revised concept for the estimation of insulin sensitivity from a single sample.
      E Raynaud, A Perez-Martin, J F Brun, A A Benhaddad and J Mercier
      Diabetes Care 1999 Jun; 22 (6): 1003-1004. https://doi.org/10.2337/diacare.22.6.1003

  3. Redmon, J B

    1. Pharmacologic induction of weight loss to treat type 2 diabetes.
      J B Redmon, S K Raatz, C A Kwong, J E Swanson, W Thomas and J P Bantle
      Diabetes Care 1999 Jun; 22 (6): 896-903. https://doi.org/10.2337/diacare.22.6.896

  4. Renard, E

    1. Implanted insulin pump may represent a chance for young women with unstable type 1 diabetes to give birth.
      P Belicar, N Jeandidier, E Renard, S Boivin, P Gross, M Pinget and V Lassmann-Vague
      Diabetes Care 1999 Jun; 22 (6): 1001-1002. https://doi.org/10.2337/diacare.22.6.1001

  5. Rigalleau, V

    1. Diabetic ketoacidosis with olanzapine treatment.
      B Gatta, V Rigalleau and H Gin
      Diabetes Care 1999 Jun; 22 (6): 1002-1003. https://doi.org/10.2337/diacare.22.6.1002

  6. Robinson, S

    1. Implications of new diagnostic criteria for abnormal glucose homeostasis in women with previous gestational diabetes.
      E Kousta, N J Lawrence, A Penny, B A Millauer, S Robinson, A Dornhorst, M de Swiet, P J Steer, A Grenfell, H M Mather, D G Johnston and M I McCarthy
      Diabetes Care 1999 Jun; 22 (6): 933-937. https://doi.org/10.2337/diacare.22.6.933

  7. Rowell, S E

    1. Excess maternal transmission of type 2 diabetes. The Northern California Kaiser Permanente Diabetes Registry.
      A J Karter, S E Rowell, L M Ackerson, B D Mitchell, A Ferrara, J V Selby and B Newman
      Diabetes Care 1999 Jun; 22 (6): 938-943. https://doi.org/10.2337/diacare.22.6.938

  8. Rowley, M J

    1. GAD antibodies in elderly men in different categories of glucose tolerance.
      H Ylihärsilä, J Tuomilehto, I R Mackay, P Zimmet, E Tuomilehto-Wolf, M J Rowley and A Nissinen
      Diabetes Care 1999 Jun; 22 (6): 996-997. https://doi.org/10.2337/diacare.22.6.996

S

  1. Sandberg, M I

    1. Switching insulin-sensitizing agents in patients with type 2 diabetes who require insulin.
      L Blonde, M I Sandberg and R D Guthrie
      Diabetes Care 1999 Jun; 22 (6): 1004-1006. https://doi.org/10.2337/diacare.22.6.1004a

  2. Schlenzka, A

    1. Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants.
      S Mäkimattila, M L Liu, J Vakkilainen, A Schlenzka, S Lahdenperä, M Syvänne, M Mäntysaari, P Summanen, R Bergholm, M R Taskinen and H Yki-Järvinen
      Diabetes Care 1999 Jun; 22 (6): 973-981. https://doi.org/10.2337/diacare.22.6.973

  3. Sekikawa, A

    1. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.
      M Tominaga, H Eguchi, H Manaka, K Igarashi, T Kato and A Sekikawa
      Diabetes Care 1999 Jun; 22 (6): 920-924. https://doi.org/10.2337/diacare.22.6.920

  4. Selby, J V

    1. Excess maternal transmission of type 2 diabetes. The Northern California Kaiser Permanente Diabetes Registry.
      A J Karter, S E Rowell, L M Ackerson, B D Mitchell, A Ferrara, J V Selby and B Newman
      Diabetes Care 1999 Jun; 22 (6): 938-943. https://doi.org/10.2337/diacare.22.6.938

  5. Sievenpiper, J L

    1. Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial.
      V Vuksan, D J Jenkins, P Spadafora, J L Sievenpiper, R Owen, E Vidgen, F Brighenti, R Josse, L A Leiter and C Bruce-Thompson
      Diabetes Care 1999 Jun; 22 (6): 913-919. https://doi.org/10.2337/diacare.22.6.913

  6. Spadafora, P

    1. Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial.
      V Vuksan, D J Jenkins, P Spadafora, J L Sievenpiper, R Owen, E Vidgen, F Brighenti, R Josse, L A Leiter and C Bruce-Thompson
      Diabetes Care 1999 Jun; 22 (6): 913-919. https://doi.org/10.2337/diacare.22.6.913

  7. Stach, B

    1. Potential impact of HbA1c determination on clinical decision making in patients with cystic fibrosis-related diabetes.
      F Hunkert, T Lietz, B Stach and W Kiess
      Diabetes Care 1999 Jun; 22 (6): 1008-1010. https://doi.org/10.2337/diacare.22.6.1008

  8. Stang, M

    1. Incidence of lactic acidosis in metformin users.
      M Stang, D K Wysowski and D Butler-Jones
      Diabetes Care 1999 Jun; 22 (6): 925-927. https://doi.org/10.2337/diacare.22.6.925

  9. Steer, P J

    1. Implications of new diagnostic criteria for abnormal glucose homeostasis in women with previous gestational diabetes.
      E Kousta, N J Lawrence, A Penny, B A Millauer, S Robinson, A Dornhorst, M de Swiet, P J Steer, A Grenfell, H M Mather, D G Johnston and M I McCarthy
      Diabetes Care 1999 Jun; 22 (6): 933-937. https://doi.org/10.2337/diacare.22.6.933

  10. Summanen, P

    1. Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants.
      S Mäkimattila, M L Liu, J Vakkilainen, A Schlenzka, S Lahdenperä, M Syvänne, M Mäntysaari, P Summanen, R Bergholm, M R Taskinen and H Yki-Järvinen
      Diabetes Care 1999 Jun; 22 (6): 973-981. https://doi.org/10.2337/diacare.22.6.973

  11. Swanson, J E

    1. Pharmacologic induction of weight loss to treat type 2 diabetes.
      J B Redmon, S K Raatz, C A Kwong, J E Swanson, W Thomas and J P Bantle
      Diabetes Care 1999 Jun; 22 (6): 896-903. https://doi.org/10.2337/diacare.22.6.896

  12. Syvänne, M

    1. Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants.
      S Mäkimattila, M L Liu, J Vakkilainen, A Schlenzka, S Lahdenperä, M Syvänne, M Mäntysaari, P Summanen, R Bergholm, M R Taskinen and H Yki-Järvinen
      Diabetes Care 1999 Jun; 22 (6): 973-981. https://doi.org/10.2337/diacare.22.6.973

T

  1. Tajima, N

    1. Effect of troglitazone on body fat distribution in type 2 diabetic patients.
      Y Mori, Y Murakawa, K Okada, H Horikoshi, J Yokoyama, N Tajima and Y Ikeda
      Diabetes Care 1999 Jun; 22 (6): 908-912. https://doi.org/10.2337/diacare.22.6.908

  2. Takala, J K

    1. Depression in subjects with type 2 diabetes. Predictive factors and relation to quality of life.
      J A Hänninen, J K Takala and S M Keinänen-Kiukaanniemi
      Diabetes Care 1999 Jun; 22 (6): 997-998. https://doi.org/10.2337/diacare.22.6.997

  3. Takamura, T

    1. Acute hyperinsulinemia reduces plasma concentrations of homocysteine in healthy men.
      Y Nagai, T Takamura, E Nohara, H Yamashita and K Kobayashi
      Diabetes Care 1999 Jun; 22 (6): 1004. https://doi.org/10.2337/diacare.22.6.1004b

  4. Taskinen, M R

    1. Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants.
      S Mäkimattila, M L Liu, J Vakkilainen, A Schlenzka, S Lahdenperä, M Syvänne, M Mäntysaari, P Summanen, R Bergholm, M R Taskinen and H Yki-Järvinen
      Diabetes Care 1999 Jun; 22 (6): 973-981. https://doi.org/10.2337/diacare.22.6.973

  5. Thomas, W

    1. Pharmacologic induction of weight loss to treat type 2 diabetes.
      J B Redmon, S K Raatz, C A Kwong, J E Swanson, W Thomas and J P Bantle
      Diabetes Care 1999 Jun; 22 (6): 896-903. https://doi.org/10.2337/diacare.22.6.896

  6. Tominaga, M

    1. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.
      M Tominaga, H Eguchi, H Manaka, K Igarashi, T Kato and A Sekikawa
      Diabetes Care 1999 Jun; 22 (6): 920-924. https://doi.org/10.2337/diacare.22.6.920

  7. Tuomilehto, J

    1. GAD antibodies in elderly men in different categories of glucose tolerance.
      H Ylihärsilä, J Tuomilehto, I R Mackay, P Zimmet, E Tuomilehto-Wolf, M J Rowley and A Nissinen
      Diabetes Care 1999 Jun; 22 (6): 996-997. https://doi.org/10.2337/diacare.22.6.996

  8. Tuomilehto-Wolf, E

    1. GAD antibodies in elderly men in different categories of glucose tolerance.
      H Ylihärsilä, J Tuomilehto, I R Mackay, P Zimmet, E Tuomilehto-Wolf, M J Rowley and A Nissinen
      Diabetes Care 1999 Jun; 22 (6): 996-997. https://doi.org/10.2337/diacare.22.6.996

  9. Turner, R C

    1. A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)
      R R Holman, C A Cull and R C Turner
      Diabetes Care 1999 Jun; 22 (6): 960-964. https://doi.org/10.2337/diacare.22.6.960

V

  1. Vakkilainen, J

    1. Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants.
      S Mäkimattila, M L Liu, J Vakkilainen, A Schlenzka, S Lahdenperä, M Syvänne, M Mäntysaari, P Summanen, R Bergholm, M R Taskinen and H Yki-Järvinen
      Diabetes Care 1999 Jun; 22 (6): 973-981. https://doi.org/10.2337/diacare.22.6.973

  2. van der Does, F E

    1. How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes?
      M Bouma, J H Dekker, J J de Sonnaville, F E van der Does, H de Vries, D M Kriegsman, P J Kostense, R J Heine and J T van Eijk
      Diabetes Care 1999 Jun; 22 (6): 904-907. https://doi.org/10.2337/diacare.22.6.904

  3. van Eijk, J T

    1. How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes?
      M Bouma, J H Dekker, J J de Sonnaville, F E van der Does, H de Vries, D M Kriegsman, P J Kostense, R J Heine and J T van Eijk
      Diabetes Care 1999 Jun; 22 (6): 904-907. https://doi.org/10.2337/diacare.22.6.904

  4. Vidgen, E

    1. Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial.
      V Vuksan, D J Jenkins, P Spadafora, J L Sievenpiper, R Owen, E Vidgen, F Brighenti, R Josse, L A Leiter and C Bruce-Thompson
      Diabetes Care 1999 Jun; 22 (6): 913-919. https://doi.org/10.2337/diacare.22.6.913

  5. Vuksan, V

    1. Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial.
      V Vuksan, D J Jenkins, P Spadafora, J L Sievenpiper, R Owen, E Vidgen, F Brighenti, R Josse, L A Leiter and C Bruce-Thompson
      Diabetes Care 1999 Jun; 22 (6): 913-919. https://doi.org/10.2337/diacare.22.6.913

W

  1. Watkins, P

    1. Central pontine myelinolysis. An unusual complication of diabetes.
      E Casey, A Evans, A Krentz, P Watkins and D Hopkins
      Diabetes Care 1999 Jun; 22 (6): 998-1000. https://doi.org/10.2337/diacare.22.6.998

  2. Williams, R

    1. Perinatal and neonatal determinants of childhood type 1 diabetes. A case-control study in Yorkshire, U.K.
      P A McKinney, R Parslow, K A Gurney, G R Law, H J Bodansky and R Williams
      Diabetes Care 1999 Jun; 22 (6): 928-932. https://doi.org/10.2337/diacare.22.6.928

  3. Woods, H F

    1. Metformin and lactic acidosis.
      R D Cohen and H F Woods
      Diabetes Care 1999 Jun; 22 (6): 1010-1011. https://doi.org/10.2337/diacare.22.6.1010

  4. Wysowski, D K

    1. Incidence of lactic acidosis in metformin users.
      M Stang, D K Wysowski and D Butler-Jones
      Diabetes Care 1999 Jun; 22 (6): 925-927. https://doi.org/10.2337/diacare.22.6.925

Y

  1. Yamashita, H

    1. Acute hyperinsulinemia reduces plasma concentrations of homocysteine in healthy men.
      Y Nagai, T Takamura, E Nohara, H Yamashita and K Kobayashi
      Diabetes Care 1999 Jun; 22 (6): 1004. https://doi.org/10.2337/diacare.22.6.1004b

  2. Yki-Järvinen, H

    1. Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants.
      S Mäkimattila, M L Liu, J Vakkilainen, A Schlenzka, S Lahdenperä, M Syvänne, M Mäntysaari, P Summanen, R Bergholm, M R Taskinen and H Yki-Järvinen
      Diabetes Care 1999 Jun; 22 (6): 973-981. https://doi.org/10.2337/diacare.22.6.973

  3. Ylihärsilä, H

    1. GAD antibodies in elderly men in different categories of glucose tolerance.
      H Ylihärsilä, J Tuomilehto, I R Mackay, P Zimmet, E Tuomilehto-Wolf, M J Rowley and A Nissinen
      Diabetes Care 1999 Jun; 22 (6): 996-997. https://doi.org/10.2337/diacare.22.6.996

  4. Yokoyama, J

    1. Effect of troglitazone on body fat distribution in type 2 diabetic patients.
      Y Mori, Y Murakawa, K Okada, H Horikoshi, J Yokoyama, N Tajima and Y Ikeda
      Diabetes Care 1999 Jun; 22 (6): 908-912. https://doi.org/10.2337/diacare.22.6.908

Z

  1. Zimmet, P

    1. GAD antibodies in elderly men in different categories of glucose tolerance.
      H Ylihärsilä, J Tuomilehto, I R Mackay, P Zimmet, E Tuomilehto-Wolf, M J Rowley and A Nissinen
      Diabetes Care 1999 Jun; 22 (6): 996-997. https://doi.org/10.2337/diacare.22.6.996
Back to top